UK Diabetes Care Devices Market Analysis and Forecasts to 2015

Report Overview

Table of Contents

2214

Select License Type

£2,214.00	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£4,427.99	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£6,641.99	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£2,214.00	Add to Wishlist
Change Currency	GBP EURO USD

Market	Healthcare and Medical
Report Type	Market Research
Country	United Kingdom
Published	30 August 2009
Number of Pages	119
Report Delivery	Email
Delivery Lead Time	-
Publisher	GlobalData

UK Diabetes Care Devices Market Analysis and Forecasts to 2015

Summary

GlobalData’s "UK Diabetes Care Devices Market Analysis and Forecasts to 2015" report provides key data, information and analysis on the UK diabetes care devices market. The report provides market landscape, competitive landscape and market trends information on two market categories – glucose monitoring and insulin delivery. The report provides comprehensive information on the key trends affecting these categories and provides key analytical insights on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.

Scope

- Forecasts & analysis of a key market within the medical device industry, diabetes care devices market, to 2015.
- Market segmentation of the diabetes care devices market in the United Kingdom (UK) into glucose monitoring and insulin delivery. Glucose monitoring further segmented into blood glucose meters and blood glucose test strips. Insulin delivery further segmented into insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories.
- Market Analysis from 2001 to 2008, including new updated 2008 data.
- Analysis of the leading companies and competitive landscape including 2008 company market share analysis.
- Analysis of key diabetes care pipeline products, new technologies and clinical trials.
- Insight into the key mergers and acquisitions (M&As), partnerships, venture capital and private equity investments.
- Qualitative analysis of market drivers, market limiters regulatory issues and future outlook.

Reasons to buy

- Understand what the new growth opportunities are within the UK diabetes care devices market.
- Develop a clear knowledge & understanding of the UK diabetes care devices competitor landscape and how this will change to 2015.
- Identify acquisition opportunities across the UK diabetes care devices market.
- Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£2,214.00	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£4,427.99	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£6,641.99	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£2,214.00	Add to Wishlist
Change Currency	GBP EURO USD

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 10
2.1 What Is This Report About? 10
3 Executive Summary 11
4 Definitions of Markets Covered in the Report 12
4.1 Diabetic Care Devices 12
4.2 Glucose Monitoring Devices 12
4.2.1 Blood Glucose Meters 12
4.2.2 Blood Glucose Strips 12
4.3 Insulin Delivery 12
4.3.1 Insulin Pens 12
4.3.2 Insulin Syringes 13
4.3.3 Insulin Pumps 13
4.3.4 Traditional Insulin Pump Accessories 13
5 Healthcare Sector Review 14
5.1 Healthcare Expenditure 14
5.2 Healthcare Infrastructure 17
5.3 Healthcare Policy 19
5.4 UK Healthcare Trade Statistics 20
6 Regulation System 21
6.1 Medical Equipment Approval Process 21
6.1.1 Classification of Medical Devices 21
6.1.2 Conformity Assessment Process 30
6.2 Medical Device approval fee 34
6.3 Post Market Surveillance (PMS) 35
7 Pricing and Reimbursement 36
7.1 Market Pricing 36
7.2 Government Policies for Reimbursement 36
8 Distribution Structure 38
9 Diabetes Care Devices In UK 39
9.1 Diabetes Care Devices, UK, Overall Revenue ($ m), 2000-2015 39
9.2 Diabetes Care Devices, UK, Category Volume (Units), 2000-2015 43
9.3 Diabetes Care Devices, UK, Key Market Trends 45
9.3.1 Increasing Prevalence of Diabetes in UK to Drive the Market 45
9.3.2 Aging Population 46
9.3.3 High Obesity Prevalence and Sedentary Lifestyles 46
9.3.4 Home Diabetes Care Driving Growth 46
9.3.5 Remote Monitoring: Increasing Diabetic Compliance 47
9.3.6 Increasing Demand for Pain Free Insulin Delivery Devices 47
9.3.7 Emergence of Continuous Glucose Monitoring (CGM) to drive Growth in the Market 47
9.3.8 Drug Stores to Remain the Major Distribution Channels 48
9.3.9 High Cost of Insulin Pumps 48
9.4 Diabetes Care Devices, UK, Company Share (2007-2008) 49
10 Glucose Monitoring In UK 51
10.1 Glucose Monitoring Overall Revenue (2000-2015) 51
10.1.1 Blood Glucose Meters Overall Revenue (2000-2015) 53
10.2 Glucose Monitoring Overall Volume (2000-2015) 55
10.2.1 Blood Glucose Meters Overall Volume (2000-2015) 56
10.3 Glucose Monitoring Average Price (2000-2015) 57
10.4 Glucose Monitoring Market Dynamics 58
10.4.1 Market Drivers 58
10.4.2 Market Restraints 58
10.5 Glucose Monitoring Distribution Share (2007-2008) 59
10.6 Glucose Monitoring, UK, Company Share (2007-2008) 60
11 Insulin Delivery In UK 62
11.1 Insulin Delivery Overall Revenue (2000-2015) 62
11.1.1 Insulin Pens Overall Revenue (2000-2015) 66
11.2 Insulin Delivery Overall Volume (2000-2015) 68
11.2.1 Insulin Pens Overall Volume (2000-2015) 69
11.3 Insulin Delivery, UK, Cross-Segment Analysis, 2000-2015 71
11.4 Insulin Delivery Average Price (2000-2015) 72
11.5 Insulin Delivery Market Dynamics 73
11.6 Insulin Delivery Distribution Share (2007-2008) 74
11.7 Insulin Delivery, UK, Company Share (2007-2008) 75
12 Overview of Key Companies in UK Diabetes Care Devices Market 77
12.1 F. Hoffmann-La Roche Ltd. 77
12.1.1 Company Overview 77
12.1.2 F. Hoffmann-La Roche Ltd Pipeline Products 80
12.2 LifeScan, Inc. 81
12.2.1 Company Overview 81
12.2.2 LifeScan, Inc. Pipeline Products 81
12.3 Bayer HealthCare AG 82
12.3.1 Company Overview 82
12.3.2 Bayer HealthCare AG Pipeline Products 85
12.4 Abbott Laboratories 86
12.4.1 Company Overview 86
12.4.2 Abbott Laboratories Pipeline Products 89
12.5 Novo Nordisk A/S 90
12.5.1 Company Overview 90
12.5.2 Novo Nordisk A/S Pipeline Products 90
12.6 Becton, Dickinson and Company 92
12.6.1 Company Overview 92
12.7 Eli Lilly and Company 94
12.7.1 Company Overview 94
12.7.2 Eli Lilly and Company Pipeline Products 97
12.8 Medtronic, Inc. 98
12.8.1 Company Overview 98
12.8.2 Medtronic, Inc. Pipeline Products 100
12.9 ARKRAY, Inc. 103
12.9.1 Company Overview 103
12.10 Terumo Corporation 103
12.10.1 Company Overview 103
12.11 Animas Corporation 106
12.11.1 Company Overview 106
12.12 Sanofi-Aventis 106
12.12.1 Company Overview 106
12.13 Smiths Medical 107
12.13.1 Company Overview 107
13 Recent Developments 110
13.1 Strategy and Business Planning 110
13.1.1 Mar 25, 2009: Smiths Medical Intents To Stop Selling Deltec Cozmo Insulin Pumps 110
13.2 Government and Public Interest 111
13.2.1 Apr 29, 2009: Warning About Failing Insulin Infusion Pump, UK 111
13.3 Product News 112
13.3.1 Mar 19, 2009: Accu-Chek Inform II Blood Glucose Monitoring System Helps To Improve Patient Care 112
13.3.2 Feb 03, 2009: Accu-Chek Aviva Nano Designed To Motivate Patients For Self-Management Of Diabetes 113
14 Appendix 114
14.1 GlobalData Research Methodology 114
14.2 Secondary Research 115
14.3 Primary Research 116
14.4 Models 116
14.5 Forecasts 117
14.6 Expert Panel Validation 117
14.7 Currency Conversion 118
14.8 Contact Us 119
14.9 Disclaimer 119

1.1 List of Tables
Table 1: Total Healthcare Expenditure ($bn), UK, 2000 – 2007 15
Table 2: Number of Doctor by Specialty in UK, 2003 - 2007 18
Table 3: UK Healthcare Trade Statistics, 2001-2006 20
Table 4: Medical Device Approval Fee in UK, 2006 34
Table 5: Diabetes Care Devices, UK, Overall Revenue ($ m), Historic, 2000-2008 39
Table 6: Diabetes Care Devices, UK, Overall Revenue ($ m), Forecast, 2008 – 2015 41
Table 7: Diabetes Care Devices, UK, Category Volume (Units), Historic, 2000-2008 43
Table 8: Diabetes Care Devices, UK, Category Volume (Units), Forecast, 2008-2015 44
Table 9: Diabetes Prevalence, UK, 2008 45
Table 10: Diabetes Prevalence by Region, UK, 2008 46
Table 11: Diabetes Care Devices, UK, Company Share by Revenue ($ m), 2007-2008 50
Table 12: Glucose Monitoring, UK, Revenue ($ m) by Segment, Historic, 2000-2008 51
Table 13: Glucose Monitoring, UK, Revenue ($ m) by Segment, Forecast, 2008-2015 52
Table 14: Blood Glucose Meters, UK, Revenue ($ m) by Sub-Segment, Historic, 2000-2008 53
Table 15: Blood Glucose Meters, UK, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015 54
Table 16: Glucose Monitoring, UK, Volume (Units) by Segment, Historic, 2000-2008 55
Table 17: Glucose Monitoring, UK, Volume (Units) by Segment, Forecast, 2008-2015 55
Table 18: Blood Glucose Meters, UK, Volume (Units) by Sub-Segment, Historic, 2000-2008 56
Table 19: Blood Glucose Meters, UK, Volume (Units) by Sub-Segment, Forecast, 2008-2015 56
Table 20: Glucose Monitoring, UK, Average Price ($), Historic, 2000-2008 57
Table 21: Glucose Monitoring, UK, Average Price ($), Forecast, 2008-2015 57
Table 22: Glucose Monitoring, UK, Distribution Share by Revenue ($ m), 2007-2008 59
Table 23: Glucose Monitoring, UK, Company Share by Revenue ($ m), 2007-2008 61
Table 24: Insulin Delivery, UK, Revenue ($ m) by Segment, Historic, 2000-2008 62
Table 25: Insulin Delivery, UK, Revenue ($ m) by Segment, Forecast, 2008-2015 64
Table 26: Insulin Pens, UK, Revenue ($ m) by Sub-Segment, Historic, 2000-2008 66
Table 27: Insulin Pens, UK, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015 67
Table 28: Insulin Delivery, UK, Volume (Units) by Segment, Historic, 2000-2008 68
Table 29: Insulin Delivery, UK, Volume (Units) by Segment, Forecast, 2008-2015 68
Table 30: Insulin Pens, UK, Volume (Units) by Sub-Segment, Historic, 2000-2008 69
Table 31: Insulin Pens, UK, Volume (Units) by Sub-Segment, Forecast, 2008-2015 70
Table 32: Insulin Delivery, UK, Cross-Segment Analysis, 2000-2015 71
Table 33: Insulin Delivery, UK, Average Price ($), Historic, 2000-2008 72
Table 34: Insulin Delivery, UK, Average Price ($), Forecast, 2008-2015 72
Table 35: Insulin Delivery, UK, Distribution Share by Revenue ($ m), 2007-2008 74
Table 36: Insulin Delivery, UK, Company Share by Revenue ($ m), 2007-2008 76
Table 37: F. Hoffmann-La Roche Ltd Pipeline Product by Equipment Type 80
Table 38: F. Hoffmann-La Roche Ltd Pipeline Product by Development Stage 80
Table 39: F. Hoffmann-La Roche Ltd Pipeline Product by Therapy Area 80
Table 40: LifeScan, Inc. Pipeline Product by Equipment Type 81
Table 41: LifeScan, Inc. Pipeline Product by Therapy Area 81
Table 42: LifeScan, Inc. Pipeline Products by Clinical Trials 81
Table 43: Bayer HealthCare AG Pipeline Products by Equipment Type 85
Table 44: Bayer HealthCare AG Pipeline Products by Development Stage 85
Table 45: Bayer HealthCare AG Pipeline Products by Therapy Area 85
Table 46: Abbott Laboratories Pipeline Products by Equipment Type 89
Table 47: Abbott Laboratories Pipeline Products by Development Stage 89
Table 48: Abbott Laboratories Pipeline Products by Therapy Area 89
Table 49: Novo Nordisk A/S Pipeline Products by Equipment Type 90
Table 50: Novo Nordisk A/S Pipeline Products By Development Stage 90
Table 51: Novo Nordisk A/S Pipeline Products By Therapy Area 91
Table 52: Novo Nordisk A/S Pipeline Products By Clinical Trials 91
Table 53: Eli Lilly and Company Pipeline Products by Equipment Type 97
Table 54: Eli Lilly and Company Pipeline Products by Development Stage 97
Table 55: Eli Lilly and Company Pipeline Products by Therapy Area 97
Table 56: Medtronic, Inc. Pipeline Products by Equipment Type 100
Table 57: Medtronic, Inc. Pipeline Products By Development Stage 101
Table 58: Medtronic, Inc. Pipeline Products By Therapy Area 101
Table 59: Medtronic, Inc. Pipeline Products By Clinical Trials 102
Table 60: USD to Local Currency, Average Exchange Rate 2008 118

1.2 List of Figures
Figure 1: Total Healthcare Expenditure ($bn), UK, 2000 – 2007 15
Figure 2: Government and Private Healthcare Expenditure (%), UK, 2007 16
Figure 3: Flowchart for Classification of Non-invasive Devices in UK, 2007 22
Figure 4: Flowchart for Classification of Invasive Devices in UK, 2007 23
Figure 5: Flowchart for Classification of Invasive Devices in UK, 2007 24
Figure 6: Flowchart for Classification of Invasive Devices in UK, 2007 25
Figure 7: Flowchart for Classification of Invasive Devices in UK, 2007 26
Figure 8: Flowchart for Classification of Active Devices in UK, 2007 27
Figure 9: Flowchart for Classification of Active Devices in UK, 2007 28
Figure 10: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in UK, 2007 29
Figure 11: Conformity Assessment of Class-I Medical Devices in UK, 2007 30
Figure 12: Conformity Assessment of Class-IIa Medical Devices in UK, 2007 31
Figure 13: Conformity Assessment of Class-IIb Medical Devices in UK, 2007 32
Figure 14: Conformity Assessment of Class-III Medical Devices in UK, 2007 33
Figure 15: Diabetes Care Devices, UK, Overall Revenue ($ m), Historic, 2000-2008 39
Figure 16: Diabetes Care Devices, UK, Overall Revenue ($ m), Forecast, 2008 – 2015 41
Figure 17: Diabetes Care Devices, UK, Category Volume (Units), Historic, 2000-2008 43
Figure 18: Diabetes Care Devices, UK, Category Volume (Units), Forecast, 2008-2015 44
Figure 19: Diabetes Prevalence in UK, 1996-2025 45
Figure 20: Diabetes Care Devices, UK, Company Share (%), 2008 49
Figure 21: Blood Glucose Meters, UK, Revenue ($ m) by Sub-Segment, Historic, 2000-2008 53
Figure 22: Blood Glucose Meters, UK, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015 54
Figure 23: Glucose Monitoring, UK, Company Share (%), 2008 60
Figure 24: Insulin Delivery, UK, Revenue ($ m) by Segment, Historic, 2000-2008 62
Figure 25: Insulin Delivery, UK, Revenue ($ m) by Segment, Forecast, 2008-2015 64
Figure 26: Insulin Pens, UK, Revenue ($ m) by Sub-Segment, Historic, 2000-2008 66
Figure 27: Insulin Pens, UK, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015 67
Figure 28: Insulin Pens, UK, Volume (Units) by Sub-Segment, Historic, 2000-2008 69
Figure 29: Insulin Pens, UK, Volume (Units) by Sub-Segment, Forecast, 2008-2015 70
Figure 30: Insulin Delivery, UK, Cross-Segment Analysis, 2000-2015 71
Figure 31: Insulin Delivery, UK, Company Share (%), 2008 75
Figure 32: GlobalData Methodology 115

Change Currency

GBP

EURO

USD

Last Viewed

UK Diabetes Care Devices Market Analysis and Forecasts to 2015

Company Financials: Koninklijke Philips Electronics N.V.

CMS Energy Corporation - Nuclear Energy - Deals and Alliances Profile

Company Financials: Ecolab, Inc.

MicroStrategy Incorporated - Financial and Strategic Analysis Review

Healthcare and Medical Company Profiles

Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Healthcare and Medical	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

UK Diabetes Care Devices Market Analysis and Forecasts to 2015

Select License Type

Speak to an Advisor

Select License Type

Table of Contents

Change Currency

Last Viewed

Healthcare and Medical Company Profiles

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel